IGF1 and breast carcinoma: In this large gene-based analysis of the insulin, IGF, GH, and LEP pathways no genes were associated with breast cancer risk after adjustment for multiple testing, but six genes carried genetic variations showing moderate to strong associations (OR>1.2 or <0.6) for breast cancer overall or an ER-defined subtype, with P values<0.01.